Skip to content
The Nexus
DossierENTITY

vaccine revenues

Coverage of vaccine revenues in the Nexus archive.

Earliest in view: Aug 8 · 10:00 UTCMost recent: Aug 8 · 10:00 UTC
Co-mentioned in this coverage
Pfizerorganization1Albert Bourlaperson1Covidtopic1
Recent coverage
  • BUSINESSAug 8 · 10:00 UTCFINANCIAL TIMES WORLD
    Pfizer grapples with ‘a world of hurt’ after Covid triumph

    Pfizer is grappling with 'a world of hurt' following its Covid triumph. The company faces mounting pressure due to sliding vaccine revenues and fears that it overpaid for new drugs. This combination of financial issues puts significant stress on boss Albert Bourla.

vaccine revenues · Dossier · The Nexus